Product Information
MOTOFEN 1-0.025 MG TABLET is a brand product labeled by Sebela Pharmaceuticals Inc., priced at $6.9253 per EA under NDC 54766020010. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
.025; 1 mg/1; mg/1
Manufacturer
Sebela Pharmaceuticals Inc.NDC
54766020010
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA017744On Market Since
4/11/2017
Pharmacological Classes
Price Statistics
The NADAC for MOTOFEN 1-0.025 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9253 per EA |
|---|---|
| All-time high | $6.9555 (Oct 15, 2025) |
| All-time low | $6.5653 (Mar 19, 2025) |
| 52-week high | $6.9555 |
| 52-week low | $6.8935 |
| Median price | $6.8935 |
| Average price | $6.7751 |
| Largest weekly change | +5.0% (Apr 9, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the difenoxin and atropine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MOTOFEN 1-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOTOFEN 1-0.025 MG TABLET, manufactured by Sebela Pharmaceuticals Inc., is $6.9253 per EA (NDC 54766020010), effective Jun 24, 2026.
How has the price of MOTOFEN 1-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOTOFEN 1-0.025 MG TABLET has risen 4.5%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MOTOFEN 1-0.025 MG TABLET?
Since Apr 17, 2024, the NADAC for MOTOFEN 1-0.025 MG TABLET has ranged from a low of $6.5653 (Mar 19, 2025) to a high of $6.9555 (Oct 15, 2025), with a median of $6.8935 per EA.
Are there cheaper alternatives to MOTOFEN 1-0.025 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MOTOFEN 1-0.025 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MOTOFEN 1-0.025 MG TABLET?
MOTOFEN 1-0.025 MG TABLET (NDC 54766020010) is labeled by Sebela Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification